Read More
Study uses metabolomics to discriminate drug-induced liver injury phenotypes
Drug-induced liver injury (DILI) is an adverse reaction to ingesting a drug, which can appear both in developmental stages, in their clinical use and even after being approved as a drug.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
- New systematic review finds low-quality evidence on the effectiveness of hangover remedies
- SARS-CoV-2 omicron variant may be less severe than the delta variant
- Healthy dietary habits help reduce risk of gestational diabetes mellitus in pregnant women
- Black men with prostate cancer may have improved response to radiation therapy than white men
Subscribe to:
Post Comments (Atom)
0 Response to "Study uses metabolomics to discriminate drug-induced liver injury phenotypes"
Post a Comment